PATENT CLAIM ANALYSIS

Application Number: 16192424
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["544", "277000"]

Abstract:
The present disclosure is directed, in part, to compounds, or pharmaceutically acceptable salts thereof, for the treatment and/or prevention of neurodegenerative disease, mitochondrial disease, fibrosis, and/or cardiomyopathy.

Claim (Index 34):
The method of  claim 28 , wherein the compound has the Formula I, Ib, IIa, II, or VII.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 98.0
- Lexical Diversity: 1.2963
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15118465', '16301200', '14815480', '14670088', '15536869']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.773229246347657
- 35 USC 102 Novelty (BERT): 0.5490181055191605
- Combined Prediction Score: 0.7508081322648074
- Mean Citation Score: 336.361582
- Max Citation Score: 415.25836
- Similarity Product: 280.78784063802954

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test